Establishment Labs (ESTA) Competitors

Establishment Labs (NASDAQ:ESTA) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment.

Does the media refer more to ESTA or TMDX?

In the previous week, Establishment Labs had 6 more articles in the media than TransMedics Group. MarketBeat recorded 10 mentions for Establishment Labs and 4 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 1.56 beat Establishment Labs' score of 0.57 indicating that TransMedics Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
TransMedics Group	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do analysts rate ESTA or TMDX?

Establishment Labs presently has a consensus price target of $56.50, indicating a potential upside of 29.50%. TransMedics Group has a consensus price target of $123.00, indicating a potential upside of 2.63%. Given Establishment Labs' stronger consensus rating and higher probable upside, equities research analysts plainly believe Establishment Labs is more favorable than TransMedics Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83
TransMedics Group	0 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.78

Which has better valuation and earnings, ESTA or TMDX?

TransMedics Group has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$166.02M	7.61	-$84.60M	-$3.05	-14.30
TransMedics Group	$441.54M	9.25	$35.46M	$1.93	62.10

Is ESTA or TMDX more profitable?

TransMedics Group has a net margin of 13.49% compared to Establishment Labs' net margin of -49.89%. TransMedics Group's return on equity of 28.02% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-49.89%	-224.34%	-25.53%
TransMedics Group	13.49%	28.02%	8.64%

Which has more volatility and risk, ESTA or TMDX?

Establishment Labs has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, TransMedics Group has a beta of 2.09, indicating that its stock price is 109% more volatile than the S&P 500.

Do insiders and institutionals hold more shares of ESTA or TMDX?

72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 99.7% of TransMedics Group shares are owned by institutional investors. 11.1% of Establishment Labs shares are owned by insiders. Comparatively, 7.0% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

TransMedics Group beats Establishment Labs on 12 of the 16 factors compared between the two stocks.